KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ACM Research (ACMR) Depreciation and Depletion (2016 - 2022)

ACM Research (ACMR) has disclosed Depreciation and Depletion for 7 consecutive years, with $1.1 million as the latest value for Q1 2022.

  • On a quarterly basis, Depreciation and Depletion rose 146.7% to $1.1 million in Q1 2022 year-over-year; TTM through Mar 2022 was $2.7 million, a 153.98% increase, with the full-year FY2023 number at $6.9 million, up 42.84% from a year prior.
  • Depreciation and Depletion was $1.1 million for Q1 2022 at ACM Research, up from $692000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.1 million in Q1 2022 to a low of $84000.0 in Q3 2018.
  • A 5-year average of $298294.1 and a median of $185000.0 in 2019 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: grew 5.71% in 2020, then surged 169.26% in 2021.
  • ACM Research's Depreciation and Depletion stood at $93000.0 in 2018, then surged by 98.92% to $185000.0 in 2019, then soared by 38.92% to $257000.0 in 2020, then soared by 169.26% to $692000.0 in 2021, then skyrocketed by 56.5% to $1.1 million in 2022.
  • Per Business Quant, the three most recent readings for ACMR's Depreciation and Depletion are $1.1 million (Q1 2022), $692000.0 (Q4 2021), and $501000.0 (Q3 2021).